Contrast-Enhanced 3-T Perfusion MRI With Quantitative Analysis for the Characterization of Musculoskeletal Tumors: Is It Worth the Trouble?

AJR. American Journal of Roentgenology
Christophe LeplatPedro Augusto Gondim Teixeira

Abstract

The purpose of this study was to evaluate the diagnostic performance of quantitative perfusion parameters in 3-T MRI for benign-malignant differentiation in musculoskeletal tumors. Ninety-five patients with histologically proven musculoskeletal tumors were prospectively included in this study. All patients underwent 3-T contrast-enhanced perfusion MRI with T1 mapping. The extended Tofts pharmacokinetic model was used to obtain four semiquantitative and four quantitative perfusion parameters for each tumor. Two radiologists evaluated all images and manually placed the ROIs in consensus. The 95 patients had 57 (59%) benign and 38 (41%) malignant tumors. Thirty-seven (39%) were bone and 58 (61%) were soft-tissue tumors. No significant differences were found in the perfusion parameters of benign and malignant tumors (p = 0.105-0.609). The best performance for benign-malignant differentiation was found for fractional volume of the extravascular extracellular space, which yielded 79% and 38% sensitivity and specificity. When soft-tissue tumors were considered, the transfer constant from plasma to the extravascular extracellular space exhibited a significant difference (p = 0.028) and had 79% and 27% sensitivity and specificity. Quant...Continue Reading

References

Oct 3, 1999·Journal of Magnetic Resonance Imaging : JMRI·H HawighorstG v Kaick
Apr 10, 2003·The British Journal of Radiology·A JacksonJ C Waterton
May 5, 2005·British Journal of Cancer·M O LeachUNKNOWN Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee, Drug Development Office, Cancer Research UK
Mar 1, 2006·Journal of Magnetic Resonance Imaging : JMRI·Caleb RobertsGeoffrey J M Parker
Jul 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mostafa Atri
Jan 11, 2007·British Journal of Cancer·J P B O'ConnorG C Jayson
Oct 16, 2009·Current Medical Imaging Reviews·Thomas E Yankeelov, John C Gore
Oct 30, 2009·Radiology·Jim S Wu, Mary G Hochman
Feb 22, 2011·Physics in Medicine and Biology·L AlicW J Niessen
Mar 9, 2011·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Steven P Sourbron, David L Buckley
Nov 24, 2011·AJR. American Journal of Roentgenology·Riham H El KhouliDavid A Bluemke
Dec 21, 2012·AJR. American Journal of Roentgenology·Marco EssigMeng Law
Aug 15, 2013·Current Opinion in Oncology·Andrew E Rosenberg
Aug 27, 2013·AJR. American Journal of Roentgenology·Andrew B RosenkrantzFang-Ming Deng
Nov 12, 2013·Diagnostic and Interventional Imaging·C A Cuenod, D Balvay
Apr 22, 2015·Current Problems in Diagnostic Radiology·Roberto García-FigueirasDow-Mu Koh
Nov 29, 2015·Magnetic Resonance Imaging Clinics of North America·Joan C VilanovaAntonio Luna
Dec 22, 2015·Journal of Magnetic Resonance Imaging : JMRI·Luc BeuzitHervé Saint-Jalmes

❮ Previous
Next ❯

Citations

Feb 1, 2019·Journal of Magnetic Resonance Imaging : JMRI·Takeshi FukudaMark E Schweitzer
Mar 10, 2020·JBJS Reviews·Costantino ErraniAndreas F Mavrogenis
Feb 20, 2021·Clinical Imaging·Oganes AshikyanAvneesh Chhabra
Dec 16, 2019·Diagnostic and Interventional Imaging·P A Gondim TeixeiraA Blum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.